Peptide157 The search results for "peptide 57" reveal a multifaceted topic encompassing various specific peptides and general peptide researchAlterations in the HLA-B*57:01 Immunopeptidome by .... While the exact meaning of "peptide 57" can vary, it most commonly refers to specific peptide sequences denoted by the number 57, or to research and products involving peptides where the number 57 is a key identifier. This can range from biologically relevant peptides like C-peptide fragments to experimental or synthetic peptides used in research and development.
The term "peptide 57" can appear in several distinct contexts, each with its own significance. The most prominent interpretation derived from the search results points towards specific peptide sequences or fragments identified by their position or designation, such as "C-Peptide (57-87)," "TAT (47-57)," or "AP-57."
C-Peptide (57-87) is a notable example. This fragment of human C-peptide is synthesized as part of proinsulin and is cleaved in the pancreas. It serves as a valuable biomarker for assessing endogenous insulin secretion, making it crucial in clinical diagnostics and research. Its structure comprises 31 amino acids, and it links the A and B chains of proinsulin before enzymatic cleavage.C-Peptide (57-87) human | CRB1000855 For research purposes, synthetic versions of C-Peptide (57-87) are available, often requiring reconstitution with PBS or H2O, and sometimes DMSO for initial mixing due to the peptide's nature. Purity levels for these research-grade peptides can vary, typically ranging from 80% to 99%.
Another significant peptide identified is AP-57. This is described as a short, basic, amphiphilic peptide with four cysteines and a net charge of +14. Research indicates its potential as a human antimicrobial peptide, with applications in injectable in situ gel-forming delivery systems. These systems, composed of AP-57 loaded nanoparticles and thermosensitive hydrogels, are being investigated for their therapeutic delivery capabilities.
Beyond biologically derived fragments, the number 57 also appears in the context of experimental and synthetic peptides with specific functions.
BMSpep-57 is recognized as a potent and competitive macrocyclic peptide inhibitor of the PD-1/PD-L1 interaction, a crucial pathway in immune regulation and cancer therapy. Its effectiveness is quantified by an IC50 value of 7.BMSpep-57is a potent and competitive macrocyclic peptide inhibitor of PD-1/PD-L1 interaction with an IC 50 of 7.68 nM.68 nM, highlighting its potential as a therapeutic agent.
Similarly, peptides like TAT (47-57) and TAT (48-57) are fragments of the HIV Tat protein, known for their cell-penetrating properties. These arginine-rich peptides can directly penetrate plasma membranes and have been explored for their ability to translocate across them, potentially aiding in drug delivery or gene therapy. Some variants, such as TAT (49-57), are modified for click chemistry, enabling further functionalization with alkyne-containing molecules.C-Peptide (57-87) Human Protein | AR31117PU-N
L57 is identified as a Low-density lipoprotein receptor-related protein 1 (LRP1)-binding peptide, exhibiting high affinity to LRP1 with a Ki of 45 nM胜肽（Peptide）是什麼？胜肽護膚品功效及好處介紹| 萬寧官方網店. This suggests potential roles in modulating LRP1-mediated processes.
The broader field of peptide research, where the number 57 might appear in less defined contexts, also warrants attention.A high quality epitope peptide forstimulation of antigen-specific T cellsin T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. For instance, research into nascent peptide codes and their role in translational control of mRNA stability and ribosome elongation rate highlights the intricate regulatory functions of even short peptide sequences.
However, the rise of experimental peptides also brings potential risks. The peptide BPC-157, while showing promise in animal studies for regenerative effects and recovery from trauma, is not approved for human clinical use. Experts warn that unregulated, lab-made peptides, often touted as cure-alls, pose serious risks and are not FDA-regulated.作者：M Yang·2015·被引用次数：46—AP-57 is a short basic amphiphilic peptidewith four cysteines and a net charge +14 (MW = 6.52, PI = 11.28). Concerns include potential negative health effects and the possibility of these substances being added to prohibited lists, particularly in athletic contexts. The "peptide concentration" itself is also a factor influencing physical stability and aggregation, a long-established principle in peptide scienceBMSpep-57 | PD-1/PD-L1 Interaction Inhibitor.
The term "peptide 57" is not a singular entity but rather a designation that can refer to various specific peptide sequences or research areas.BMSpep-57is a potent and competitive macrocyclic peptide inhibitor of PD-1/PD-L1 interaction with an IC 50 of 7.68 nM. From clinically significant biomarkers like C-peptide fragments to experimental compounds like AP-57 and BMSpep-57, and even to unregulated substances like BPC-157, the context is crucial for understanding its meaning and implications. While peptides hold immense potential in medicine and research, critical evaluation of their origin, regulation, and documented effects is essential, especially when considering experimental or novel peptide compounds.
Join the newsletter to receive news, updates, new products and freebies in your inbox.